Neoadjuvant chemotherapy followed by minimally invasive esophagectomy is safe and feasible for treatment of esophageal squamous cell carcinoma
Author:
Affiliation:
1. Department of Thoracic Surgery; Peking University Third Hospital; Beijing China
2. Cancer Research Program, Julius L. Chambers Biomedical Biotechnology Research Institute; North Carolina Central University; Durham North Carolina USA
Funder
Development Center for Medical Science and Technology, China National Health and Family Planning Commission
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine,Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/1759-7714.12590/fullpdf
Reference25 articles.
1. Therapeutic strategies in oesophageal carcinoma: Role of surgery and other modalities;Mariette;Lancet Oncol,2007
2. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study-JCOG9204;Ando;J Clin Oncol,2003
3. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: An updated meta-analysis;Sjoquist;Lancet Oncol,2011
4. Postoperative morbidity and mortality rates are not increased for patients with gastric and gastroesophageal cancer who undergo preoperative chemoradiation therapy;Badgwell;Ann Surg Oncol,2016
5. CMISG1701: A multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT3-4aN0-1M0) (NCT03001596);Tang;BMC Cancer,2017
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Does neoadjuvant therapy contribute to increased risk in anastomotic leakage of esophageal cancer? A network meta‐analysis;Journal of Evidence-Based Medicine;2024-08-19
2. Risk Factors Associated With Anastomotic Stricture in Patients Undergoing Minimally Invasive Esophagectomy: Experience From a High-Volume Center;Cureus;2024-08-07
3. Impact of treatment interval between neoadjuvant immunochemotherapy and surgery in lung squamous cell carcinoma;BMC Cancer;2024-05-13
4. Comparisons of short-term outcomes between robot-assisted, video-assisted, and open esophagectomy for resectable esophageal cancer after neoadjuvant treatment: a retrospective study;Journal of Thoracic Disease;2024-03
5. Impacts of additional cycles of neoadjuvant immunotherapy on surgery in non‐small‐cell lung cancer;Thoracic Cancer;2023-04-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3